A method for reduced time and stress myocardial creatine kinase measurements using 31P-MRS at 3T is presented. The new method is validated in healthy controls and demonstrated in 27 obese and heart-failure patients. In addition, the existing TRiST method is applied in 63 subjects for the first time on a Siemens platform.
This abstract and the presentation materials are available to members only; a login is required.